Sign In
Buy CRNX
$33.09
+0.480 (+1.47%)
At Close: Jun 03, 2026
Q1 2020 EPS Estimates for Crinetics Pharmaceuticals Inc Raised by SVB Leerink (NASDAQ:CRNX)
05:32am, Saturday, 14'th Mar 2020
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) – Investment analysts at SVB Leerink increased their Q1 2020 EPS estimates for shares of Crinetics Pharmaceuticals in a research report issued to clients
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 12.)
Masimo...
Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and Trillium Therapeutics (TRIL)
11:14am, Wednesday, 11'th Mar 2020
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on ChemoCentryx (CCXI), Crinetics Pharmaceuticals (CRNX) and
Companies in the
Healthcare sector have received a lot of coverage today as analysts
weigh in on ChemoCentryx (
CCXI
–
Research Report
), Crinetics Pharmaceuticals (
CRNX
–
Research Report
) and T
BRIEF-Crinetics Pharmaceuticals Reports Q4 Loss Per Share Of $0.60
09:37pm, Monday, 09'th Mar 2020
Crinetics Pharmaceuticals Inc:
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
08:10pm, Monday, 09'th Mar 2020
SAN DIEGO, March 09, 2020 -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization.
Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
08:10pm, Monday, 09'th Mar 2020
SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the...
These 14 Stocks Are Stupid Cheap
07:00pm, Sunday, 08'th Mar 2020
The coronavirus induced sell-off has created a number of attractive buying opportunities.
Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for
05:30pm, Wednesday, 04'th Mar 2020
Crinetics Pharmaceuticals, Inc. (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Crinetics Pharmaceuticals, Inc. (CRNX) to Report a Decline in Earnings: What to Look Out for
05:30pm, Wednesday, 04'th Mar 2020
Crinetics Pharmaceuticals, Inc. (CRNX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Crinetics Pharmaceuticals (NASDAQ:CRNX) Lowered to Hold at BidaskClub
08:18am, Wednesday, 04'th Mar 2020
Crinetics Pharmaceuticals (NASDAQ:CRNX) was downgraded by equities researchers at BidaskClub from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Wedn
Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Shares Purchased by Fmr LLC
12:18pm, Monday, 02'nd Mar 2020
Fmr LLC increased its holdings in shares of Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) by 0.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissi
19,100 Shares in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) Bought by California Public Employees Retirement System
11:20am, Monday, 02'nd Mar 2020
California Public Employees Retirement System bought a new position in Crinetics Pharmaceuticals Inc (NASDAQ:CRNX) in the 4th quarter, according to its most recent disclosure with the Securities & Exc
The Crinetics Pharmaceuticals (NASDAQ:CRNX) Share Price Is Down 12% So Some Shareholders Are Getting Worried
01:27pm, Friday, 28'th Feb 2020
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...
Crinetics Pharmaceuticals (NASDAQ:CRNX) Lowered to "Hold" at ValuEngine
09:46am, Tuesday, 25'th Feb 2020
ValuEngine downgraded shares of Crinetics Pharmaceuticals (NASDAQ:CRNX) from a buy rating to a hold rating in a report released on Friday, ValuEngine reports. Several other research analysts have also
